Beta-1,4-Galactosyltransferase II Predicts Poor Prognosis of Patients With Non-Metastatic Clear-Cell Renal Cell Carcinoma

Tumor Biology - United States
doi 10.1177/1010428317691417
Full Text
Abstract

Available in full text

Date
Authors
Publisher

SAGE Publications

Related search

High Kinesin Family Member 11 Expression Predicts Poor Prognosis in Patients With Clear Cell Renal Cell Carcinoma

Journal of Clinical Pathology
MedicineForensic MedicinePathology
2019English

High Expression of Stearoyl-CoA Desaturase 1 Predicts Poor Prognosis in Patients With Clear-Cell Renal Cell Carcinoma

PLoS ONE
Multidisciplinary
2016English

High Expression of FER Tyrosine Kinase Predicts Poor Prognosis in Clear Cell Renal Cell Carcinoma

Oncology Letters
Cancer ResearchOncology
2012English

High Expression of HMGA2 Predicts Poor Survival in Patients With Clear Cell Renal Cell Carcinoma

OncoTargets and Therapy
OncologyPharmacology
2016English

Decreased TCL6 Expression Is Associated With Poor Prognosis in Patients With Clear Cell Renal Cell Carcinoma

Oncotarget
Oncology
2016English

Prognostic Value of Granulocyte Colony-Stimulating Factor in Patients With Non-Metastatic Clear Cell Renal Cell Carcinoma

Oncotarget
Oncology
2017English

High Expression Level of MMP9 Is Associated With Poor Prognosis in Patients With Clear Cell Renal Carcinoma

PeerJ
GeneticsMolecular BiologyBiochemistryBiological SciencesMedicineAgriculturalNeuroscience
2018English

Potential Roles for PD‐1 and Cabozantinib in Patients With Metastatic Non‐Clear Cell Renal Cell Carcinoma

Oncologist
Cancer ResearchMedicineOncology
2019English

Clinical Impact of Targeted Therapies in Patients With Metastatic Clear-Cell Renal Cell Carcinoma

OncoTargets and Therapy
OncologyPharmacology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy